PTBP1 dysregulation has been linked to the onset and development of prostate and ovarian cancer, whereas PTBP1 overexpression is associated with the aggressiveness of glioma, colorectal and breast cancer55–57. This evidence concerns the gene PTBP1 and central nervous system cancer.